C12N 2770/24252
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2770/24252 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 6 US grants and 15 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 15
- Assignees
- 23
- Inventors
- 45
- Latest grant
- 16 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 0 | 2 |
| 2012 | 2 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 3 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 2 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method of purifying whole virus particles16 Dec 2025US 12,497,598 B2Hvidovre Hospital
- HCV culture systems and direct-acting antiviral sensitivity23 Oct 2018US 10,106,783 B2Hvidovre Hospital
- Methods for producing cells having a phenotype of a primary human hepatocytes and compositions15 May 2018US 9,969,979 B2The Governors of the University of Alberta
- HCV full-length infectious cell culture systems and applications thereof5 Jul 2016US 9,382,517 B2Hvidovre Hospital
- Recombinant human hepatitis C virus-like particle and method for producing the same22 May 2012US 8,183,044 B2Japan AS Represented By Director-General of National Institute of Infectious Diseases
- Vsv vector-encoded hcv envelope proteins e1/e2 as vaccines against hepatitis c virus15 Jan 2026US 2026/0015593 A1Twincore Zentrum FüR Experimentelle Und Klinische Infektionsforschung GmbH
- Self-cleaving polyproteins and uses thereof6 Nov 2025US 2025/0339512 A1The University of Melbourne
- Compositions and methods for producing glyco-modified viral antigens28 Mar 2024US 2024/0100154 A1Danmarks Tekniske Universitet
- Method of purifying whole virus particles31 Aug 2023US 2023/0272350 A1Hvidovre Hospital
- Novel hcv culture systems and direct-acting antiviral sensitivity25 Aug 2016US 2016/0244729 A1Hvidovre Hospital
Most cited
By later US patents
- HCV full-length infectious cell culture systems and applications thereof5US 9,382,517 B2Hvidovre Hospital · 2016
- HCV culture systems and direct-acting antiviral sensitivity1US 10,106,783 B2Hvidovre Hospital · 2018
- High production system for infectious hepatitis C virus particle1US 8,143,022 B2Tokyo Metropolitan Institute of Medical Science · 2012
- Recombinant human hepatitis C virus-like particle and method for producing the same1US 8,183,044 B2Japan AS Represented By Director-General of National Institute of Infectious Diseases · 2012